Please provide your email address to receive an email when new articles are posted on . When treated separately, 71% of patients treated for frown lines and 45% treated for crow’s feet saw ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma announced today positive topline results from the phase III READY-3 clinical trial investigating the use of RelabotulinumtoxinA for the treatment of ...

The US Food and Drug Administration (FDA) has approved daxibotulinumtoxinA-lanm injection (Daxxify) for the temporary improvement in the appearance of moderate to severe glabellar lines (frown lines) ...

One of the first signs of growing older are frown lines between the eyebrows. Millennials, it seems, want none of that. As far back as 2016, Modern Aesthetics had reported that “millennials consider ...

Please provide your email address to receive an email when new articles are posted on . 92%, 62% and 60% of subjects were satisfied with their outcomes at months 1, 6 and 12 post-treatment, ...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma announced today topline results from two phase IIIb trials investigating RelabotulinumtoxinA for the treatment of glabellar lines (GL – frown lines) and ...

The United States Food and Drug Administration (FDA) has approved Revance Therapeutics’ (NASDAQ:RVNC) lead asset DAXXIFY (DaxibotulinumtoxinA-lanm) for injection for the temporary improvement of ...

I sprung for Botox the year I turned 30, and I now can’t imagine my life before this magical toxin. With the prick of a needle, my crow's feet disappear and I’m rendered emotionless thanks to its ...